APA (7 वां संस्करण) प्रशस्ति पत्र

van der Heijde, D., Dijkmans, B., Schiff, M., Kivitz, A., de Vlam, K., Wordsworth, P., . . . Grp, A. (2008). Maintenance of reduction in disease activity and partial remission in patients with Ankylosing spondylitis (AS) - 3-year results from the adalimumab (HUMIRO) trial evaluating long-term efficacy and safety in AS (ATLAS).

शिकागो शैली (17वां संस्करण) प्रशस्ति पत्र

van der Heijde, D., et al. Maintenance of Reduction in Disease Activity and Partial Remission in Patients with Ankylosing Spondylitis (AS) - 3-year Results from the Adalimumab (HUMIRO) Trial Evaluating Long-term Efficacy and Safety in AS (ATLAS). 2008.

एमएलए (9वां संस्करण) प्रशस्ति पत्र

van der Heijde, D., et al. Maintenance of Reduction in Disease Activity and Partial Remission in Patients with Ankylosing Spondylitis (AS) - 3-year Results from the Adalimumab (HUMIRO) Trial Evaluating Long-term Efficacy and Safety in AS (ATLAS). 2008.

चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.